Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 34, 2023 - Issue 1
Submit an article Journal homepage
2,852
Views
7
CrossRef citations to date
0
Altmetric
Letter to the Editor

New-onset and flares of psoriasis after COVID-19 infection or vaccination successfully treated with biologics: a case series

Luigi Gargiuloa Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, MI, USA;b Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, ItalyView further author information
,
Luciano Ibbaa Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, MI, USA;b Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, ItalyCorrespondence[email protected]
View further author information
,
Carlo A. Vignolia Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, MI, USA;b Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, ItalyView further author information
,
Francesco Piscazzia Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, MI, USA;b Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, ItalyView further author information
,
Andrea Cortesea Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, MI, USA;b Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, ItalyView further author information
,
Giovanni Fiorilloa Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, MI, USA;b Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, ItalyView further author information
,
Francesco Tosoa Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, MI, USA;b Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, ItalyView further author information
,
Giulia Paviaa Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, MI, USA;b Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, ItalyView further author information
,
Mario Valentia Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, MI, USA;b Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, ItalyView further author information
,
Jessica Avaglianoa Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, MI, USAView further author information
,
Alessandra Narcisia Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, MI, USAView further author information
&
Antonio Costanzoa Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, MI, USA;b Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, ItalyView further author information
 show all
Article: 2198050 | Received 26 Mar 2023, Accepted 27 Mar 2023, Published online: 10 Apr 2023

References

  • Mohseni Afshar Z, Babazadeh A, Hasanpour A, et al. Dermatological manifestations associated with COVID-19: a comprehensive review of the current knowledge. J Med Virol. 2021;93(10):1–3.
  • Wack S, Patton T, Ferris LK. COVID-19 vaccine safety and efficacy in patients with immune-mediated inflammatory disease: review of available evidence. J Am Acad Dermatol. 2021;85(5):1274–1284.
  • Avallone G, Maronese CA, Conforti C, et al. Real-world data on primary cutaneous lymphoproliferative disorders following SARS-CoV-2 vaccination: a multicentre experience from tertiary referral hospitals. Acad Dermatol Venereol. 2023;37(4):e451–e455.
  • Nasiri S, Araghi F, Tabary M, et al. A challenging case of psoriasis flare-up after COVID-19 infection. J Dermatolog Treat. 2020;31(5):448–449.
  • Bellinato F, Maurelli M, Gisondi P, et al. Cutaneous adverse reactions associated with SARS-CoV-2 vaccines. J Clin Med. 2021;10(22):5344.
  • Freeman EE, McMahon DE. Creating dermatology guidelines for COVID-19: the pitfalls of applying evidence-based medicine to an emerging infectious disease. J Am Acad Dermatol. 2020;82(6):e231–e232.
  • Gisondi P, Fargnoli MC, Amerio P, et al. Italian adaptation of EuroGuiDerm guideline on the systemic treatment of chronic plaque psoriasis. Ital J Dermatol Venerol. 2022;157(Suppl. 1 to No. 1):1–78.
  • Wu PC, Huang IH, Wang CW, et al. New onset and exacerbations of psoriasis following COVID-19 vaccines: a systematic review. Am J Clin Dermatol. 2022;23(6):775–799.
  • Eyerich K, Weisenseel P, Pinter A, et al. IL-23 blockade with guselkumab potentially modifies psoriasis pathogenesis: rationale and study protocol of a phase 3b, randomised, double-blind, multicentre study in participants with moderate-to-severe plaque-type psoriasis (GUIDE). BMJ Open. 2021;11(9):e049822.
  • Pavia G, Gargiulo L, Spinelli F, et al. Generalized pustular psoriasis flare in a patient affected by plaque psoriasis after BNT162b2 mRNA COVID-19 vaccine, successfully treated with risankizumab. J Eur Acad Dermatol Venereol. 2022;36(7):e502–e505.
  • Gelfand JM, Armstrong AW, Bell S, et al. National psoriasis foundation COVID-19 task force guidance for management of psoriatic disease during the pandemic: version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments. J Am Acad Dermatol. 2021;84(5):1254–1268.
  • Narcisi A, Valenti M, Gargiulo L, et al. Real-life effectiveness of tildrakizumab in chronic plaque psoriasis: a 52-week multicentre retrospective study-IL PSO (Italian landscape psoriasis). Acad Dermatol Venereol. 2023;37(1):93–103.
  • Lebwohl M, Rivera-Oyola R, Murrell DF. Should biologics for psoriasis be interrupted in the era of COVID-19? J Am Acad Dermatol. 2020;82(5):1217–1218.
  • Gargiulo L, Ibba L, Malagoli P, et al. Real-life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: a 104-week multicenter retrospective study - IL PSO (ITALIAN LANDSCAPE PSORIASIS). Acad Dermatol Venereol. 2023;00:1–11.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.